COMPASS Pathways plc (CMPS)
Largest Insider Buys in Sector
CMPS Stock Price History Chart
CMPS Stock Performance
About COMPASS Pathways plc
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United …
Insider Activity of COMPASS Pathways plc
Over the last 12 months, insiders at COMPASS Pathways plc have bought $0 and sold $28.34M worth of COMPASS Pathways plc stock.
On average, over the past 5 years, insiders at COMPASS Pathways plc have bought $0 and sold $14.37M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
List of Insider Buy and Sell Transactions, COMPASS Pathways plc
| 2024-10-24 | Sale | 10 percent owner | 1.55M – | $0 | $0 | 0.00% | ||
| 2024-10-24 | Sale | 10 percent owner | 1.55M – | $0 | $0 | 0.00% | ||
| 2024-09-26 | Sale | 10 percent owner | 2.66M 3.3714% | $6.05 | $16.09M | 0.00% | ||
| 2024-05-21 | Sale | 10 percent owner | 17,800 0.0262% | $7.91 | $140,759 | -12.45% | ||
| 2024-05-21 | Sale | 10 percent owner | 17,800 0.0262% | $7.91 | $140,759 | -12.45% | ||
| 2024-05-20 | Sale | 10 percent owner | 13,407 0.0195% | $7.89 | $105,808 | -13.21% | ||
| 2024-05-20 | Sale | 10 percent owner | 13,407 0.0195% | $7.89 | $105,808 | -13.21% | ||
| 2024-05-03 | Sale | 10 percent owner | 37,523 0.0663% | $8.82 | $330,904 | -18.46% | ||
| 2024-05-03 | Sale | 10 percent owner | 37,523 0.0663% | $8.82 | $330,904 | -18.46% | ||
| 2024-05-02 | Sale | 10 percent owner | 19,243 0.0312% | $8.29 | $159,528 | -15.38% | ||
| 2024-05-02 | Sale | 10 percent owner | 19,243 0.0312% | $8.29 | $159,528 | -15.38% | ||
| 2024-04-17 | Sale | 10 percent owner | 21,700 0.0361% | $8.78 | $190,615 | -17.52% | ||
| 2024-04-17 | Sale | 10 percent owner | 21,700 0.0361% | $8.78 | $190,615 | -17.52% | ||
| 2024-04-16 | Sale | 10 percent owner | 47,761 0.0749% | $8.53 | $407,349 | -18.85% | ||
| 2024-04-16 | Sale | 10 percent owner | 47,761 0.0749% | $8.53 | $407,349 | -18.85% | ||
| 2024-04-01 | Sale | 10 percent owner | 51,500 0.082% | $8.96 | $461,332 | -25.10% | ||
| 2024-04-01 | Sale | 10 percent owner | 51,500 0.082% | $8.96 | $461,332 | -25.10% | ||
| 2024-03-28 | Sale | 10 percent owner | 51,500 0.0865% | $8.65 | $445,552 | -12.74% | ||
| 2024-03-28 | Sale | 10 percent owner | 51,500 0.0865% | $8.65 | $445,552 | -12.74% | ||
| 2024-03-13 | Sale | 34,406 0.056% | $10.80 | $371,753 | -30.26% |
Institutional Investor Ownership
| Tcg Crossover Management Llc | $32.1M | 5.64 | 3.86M | 0% | +$0 | 0.05 | |
| Citadel Advisors LLC | $32.08M | 5.64 | 3.86M | +146.41% | +$19.06M | 0.02 | |
| Millennium Management LLC | $26.84M | 4.72 | 3.23M | +2,975.2% | +$25.96M | 0.02 | |
| Paradigm BioCapital Advisors LP | $19.89M | 3.5 | 2.39M | +5.52% | +$1.04M | 0.72 | |
| ARK Investment Management LLC | $17.98M | 3.16 | 2.16M | -17.48% | -$3.81M | 0.06 |